| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281852 | Clinical Gastroenterology and Hepatology | 2015 | 35 Pages |
Abstract
We found that continuation of immunomodulators after “stepping up” to anti-TNF therapy did not improve outcomes but was associated with an increased risk of opportunistic infection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Mark T. Osterman, Kevin Haynes, Elizabeth Delzell, Jie Zhang, Meenakshi Bewtra, Colleen M. Brensinger, Lang Chen, Fenglong Xie, Jeffrey R. Curtis, James D. Lewis,